These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27729247)

  • 1. High fructose-mediated attenuation of insulin receptor signaling does not affect PDGF-induced proliferative signaling in vascular smooth muscle cells.
    Osman I; Poulose N; Ganapathy V; Segar L
    Eur J Pharmacol; 2016 Nov; 791():703-710. PubMed ID: 27729247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.
    Zhao Y; Biswas SK; McNulty PH; Kozak M; Jun JY; Segar L
    Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1375-85. PubMed ID: 21325637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
    Osman I; Segar L
    Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
    Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
    Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation.
    Perez J; Torres RA; Rocic P; Cismowski MJ; Weber DS; Darley-Usmar VM; Lucchesi PA
    Am J Physiol Cell Physiol; 2011 Jul; 301(1):C242-51. PubMed ID: 21451101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.
    Shawky NM; Segar L
    Pharmacol Res; 2017 May; 119():251-264. PubMed ID: 28212891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway.
    Kim JY; Kim KH; Lee WR; An HJ; Lee SJ; Han SM; Lee KG; Park YY; Kim KS; Lee YS; Park KK
    Vascul Pharmacol; 2015 Jul; 70():8-14. PubMed ID: 25737404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meso-dihydroguaiaretic acid inhibits rat aortic vascular smooth muscle cell proliferation by suppressing phosphorylation of platelet-derived growth factor receptor beta.
    Song MC; Kim EC; Kim WJ; Kim TJ
    Eur J Pharmacol; 2014 Dec; 744():36-41. PubMed ID: 25261039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camptothecin inhibits platelet-derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells through inhibition of PI3K/Akt signaling pathway.
    Park ES; Kang SI; Yoo KD; Lee MY; Yoo HS; Hong JT; Shin HS; Kim B; Yun YP
    Exp Cell Res; 2013 Apr; 319(7):982-91. PubMed ID: 23328306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rβ phosphorylation.
    Yoo KD; Park ES; Lim Y; Kang SI; Yoo SH; Won HH; Lee HP; Kim YH; Yoo ID; Yoo HS; Hong JT; Yun YP
    Vascul Pharmacol; 2012; 56(1-2):91-7. PubMed ID: 22166585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation.
    Martin-Garrido A; Williams HC; Lee M; Seidel-Rogol B; Ci X; Dong JT; Lassègue B; Martín AS; Griendling KK
    PLoS One; 2013; 8(11):e79657. PubMed ID: 24236150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taurine suppresses platelet-derived growth factor (PDGF) BB-induced PDGF-beta receptor phosphorylation by protein tyrosine phosphatase-mediated dephosphorylation in vascular smooth muscle cells.
    Yoshimura H; Nariai Y; Terashima M; Mitani T; Tanigawa Y
    Biochim Biophys Acta; 2005 Sep; 1745(3):350-60. PubMed ID: 16112211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin Calcium Inhibits PDGF-ββ-Induced Proliferation and Migration of VSMCs Through the G0/G1 Cell Cycle Arrest and Suppression of Activated PDGFRβ-PI3K-Akt Signaling Cascade.
    Chen S; Dong S; Li Z; Guo X; Zhang N; Yu B; Sun Y
    Cell Physiol Biochem; 2017; 44(1):215-228. PubMed ID: 29131001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway.
    Park ES; Lim Y; Hong JT; Yoo HS; Lee CK; Pyo MY; Yun YP
    Vascul Pharmacol; 2010; 53(1-2):61-7. PubMed ID: 20398797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation.
    Seo J; Lee HS; Ryoo S; Seo JH; Min BS; Lee JH
    Eur J Pharmacol; 2011 Dec; 673(1-3):56-64. PubMed ID: 22040922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
    Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
    Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of BST406, a newly synthesized benzylideneacetophenone derivative, on abnormal vascular smooth muscle cell proliferation.
    Kim TJ; Han HJ; Kim YJ; Jung JC; Yu JY; Lee JJ; Yun YP
    Biol Pharm Bull; 2010; 33(5):900-4. PubMed ID: 20460774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins.
    Begum N; Hockman S; Manganiello VC
    J Biol Chem; 2011 Jul; 286(29):26238-49. PubMed ID: 21632535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition.
    Chang Y; Li JY; Jayakumar T; Hung SH; Lee WC; Manubolu M; Sheu JR; Hsu MJ
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.